Status:
COMPLETED
Comparison Between Dual Energy/Subtraction CT With MRI for the Identification of Predictors of Malignancy in Cystic Pancreatic Lesions
Lead Sponsor:
University Health Network, Toronto
Conditions:
Pancreatic Cyst
Eligibility:
All Genders
40-100 years
Phase:
NA
Brief Summary
Cystic pancreatic lesions are increasingly detected incidentally in imaging studies, reportedly in up to 45% of the abdominal Magnetic Resonance (MR) examinations. The majority of these lesions have p...
Detailed Description
With the rapid technological advancement, growth and widespread use of cross-sectional imaging, there has been increased detection of pancreatic cystic lesions (PCs). The reported incidence of pancrea...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Patients of all ethnic groups older than 40 years old
- Cystic pancreatic lesions larger than 1 cm documented by MR
- Scheduled for surgery (Group 1) or undergoing surveillance (Group 2) for a pancreatic cyst by a hepatobiliary surgeon at UHN (University Health Network)
- Exclusion criteria:
- Patients with contraindication for contrast-enhanced CT or MRI
- Pregnancy
- Patients who do not consent to the study
- Patients younger than 40 years old or with pancreatic cysts less than 1 cm
Exclusion
Key Trial Info
Start Date :
July 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2023
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT03320733
Start Date
July 1 2018
End Date
November 30 2023
Last Update
March 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Toronto, Department of Medical Imaging
Toronto, Ontario, Canada, M5G 2N2